Search terms
Results 1 - 3 of 3 - ordered by :

Stress-related pathophysiological changes, such as lowered arrhythmic threshold and increased sympathetic activation with related increases in blood pressure and heart rate, as well as ...

Date : 24/04/2018

Prof. Mirza Dilic, MD, PhD, FESC, FACC National CVD Prevention Coordinator of the Federation of Bosnia and Herzegovina/Bosnia and Herzegovina Contact: email Prof. Dusko Vulic, MD,PhD,FESC,FACC ...

Date : 17/12/2015

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 20/10/2015